Editor's Note Glucagon-like peptide-1 (GLP-1) receptor agonists may offer orthopedic patients with obesity and type 2 diabetes a powerful tool for preoperative weight loss and potential disease modification, according to a July 10 review article in The Journal of Bone and Joint Surgery. However, the agents carry perioperative risks that…

Read More

Editor's Note Research shows using GLP-1 receptor agonists both before and after bariatric surgery is associated with greater total weight loss than surgery alone, according to a July 13 article in MedPage Today. The article focuses on a retrospective analysis of 568 patients presented at ENDO 2025, the annual meeting…

Read More

Editor's Note Bariatric surgery produced five times greater weight loss than GLP-1 medications in a new study of over 51,000 patients with obesity, according to a June 18 article from Fox News. The retrospective study, funded by the NIH and conducted by researchers at NYU Langone Health and NYC Health…

Read More

Editor's Note Bariatric surgery improves survival and appears cost-effective over a decade for patients with obesity and compensated cirrhosis, according to an April 18 report in Healio. The findings, based on an analysis published in JAMA Surgery, suggest that bariatric surgery could fill a crucial gap in care for this…

Read More

Editor's Note New research shows bariatric surgery may offer better outcomes and lower overall spending than lifestyle changes for patients with cirrhosis, especially mild cases, Medscape reported April 9. The article focuses on a study published in Jama Surgery detailing both the survival benefits and long-term cost-effectiveness for patients with…

Read More

Editor's Note The widespread adoption of GLP-1 weight-loss medications like Ozempic and Wegovy could put revenue at risk across multiple service lines, according to a March 11 article in Becker’s Hospital Review. As a result, hospitals and ambulatory surgery centers (ASCs) face critical questions about how to adapt. The article…

Read More

Editor's Note A study presented at the 2024 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting has revealed a significant correlation between financial conflicts of interest and favorable research outcomes in robotic bariatric surgery, General Surgery News January 18 reports. The article noted this concerning trend: authors who…

Read More

Editor's Note Despite a rise in discussions about bariatric surgery, a retrospective study spanning two decades revealed persistent racial and gender disparities in which patients undergo the procedure. MedPage Today reported the news January 16. The analysis, involving 122,487 patients, showed that only 9.1% with class II obesity or higher…

Read More

Editor's Note A recent survey from Orlando Health highlights limited awareness of the link between bariatric surgery and improved fertility, with only half of respondents acknowledging its benefits. According to January 16 coverage in Contemporary OB/GYN, the findings underscore a broader knowledge gap among the US population regarding the role…

Read More

Editor's Note Bariatric surgery programs nationwide have reported a 20-25% decline in surgical volumes over the past year amid the rising use of glucagon-like peptide-1 (GLP-1) medications for obesity, OR Management News reported Dec 2. Although the connection between the decline and the popularity of the drugs cannot be definitively…

Read More